Hemogenyx Pharmaceuticals (HEMO)

Sector:

Pharma and Biotech

337.00p
   
  • Change Today:
    -1.50p
  • 52 Week High: 1,342.00
  • 52 Week Low: 320.00
  • Currency: UK Pounds
  • Shares Issued: 3.60m
  • Volume: 11,028
  • Market Cap: £12.15m
  • RiskGrade: 340

Regulatory News

Total Voting Rights 31-Jan-2025 09:35 RNS
Placing to raise £340,000 08-Jan-2025 07:00 RNS
Change of Company Secretary and Registered Office 02-Jan-2025 07:00 RNS
Total Voting Rights 31-Dec-2024 07:00 RNS
Opening of First Clinical Site 30-Dec-2024 07:00 RNS
Ultrafast CAR-T Manufacturing 19-Dec-2024 07:00 RNS
Admission of New Ordinary Shares and New ISIN 10-Dec-2024 16:10 RNS
Result of Extraordinary General Meeting 09-Dec-2024 13:30 RNS
Site Initiation Visit Completed 09-Dec-2024 07:00 RNS
CBR Macrophage Delivery Update 06-Dec-2024 07:00 RNS
Total Voting Rights 29-Nov-2024 07:00 RNS
Notice of Extraordinary General Meeting 22-Nov-2024 12:49 RNS
IRB Approval for Phase I Clinical Trial 22-Nov-2024 07:00 RNS
Institutional Investment 11-Nov-2024 07:00 RNS
Schedule for Phase I Clinical Trial Opening 30-Oct-2024 07:00 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HEMO Market Data

Currency UK Pounds
Share Price 337.00p
Change Today -1.50p
% Change -0.44 %
52 Week High 1,342.00
52 Week Low 320.00
Volume 11,028
Shares Issued 3.60m
Market Cap £12.15m
RiskGrade 340

HEMO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
44.23% below the market average44.23% below the market average44.23% below the market average44.23% below the market average44.23% below the market average
50% below the sector average50% below the sector average50% below the sector average50% below the sector average50% below the sector average
Price Trend
86.12% below the market average86.12% below the market average86.12% below the market average86.12% below the market average86.12% below the market average
71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average
Income Not Available
Growth Not Available

HEMO Dividends

No dividends found

Trades for 14-Feb-2025

Time Volume / Share Price
16:23 259 @ 327.23p
15:59 312 @ 327.23p
15:57 88 @ 331.61p
15:18 29 @ 339.00p
13:34 293 @ 327.24p

HEMO Key Personnel

CEO Vladislav Sandler Ph.D.

Top of Page